SCHEMBL175118

SCHEMBL175118

COc1cccc(NC(=O)Nc2cccc3c2CCN3)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.58
ALDH1A1 P00352 4/20 0.58
HTT P42858 4/20 0.58
MAPT P10636 8/20 0.57
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
TP53 P04637 2/20 0.55
TSHR P16473 1/20 0.55
NPC1 O15118 5/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
TRPV1 Q8NER1 1/20 0.53
MITF O75030 1/20 0.52
PKM P14618 1/20 0.52
KDR P35968 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 1/20 0.50
MAPK1 P28482 1/20 0.50
STAT1 P42224 1/20 0.50
RAF1 P04049 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175262 0.88 SMN1; SMN2 (0.55) RAB9AMAPTKMT2AMEN1TP53
SCHEMBL174986 0.84 KMT2A (0.52) RAB9AMAPTKMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL174066 0.83 KMT2A (0.51) RAB9AMAPTKMT2AMEN1NPC1
SCHEMBL173758 0.83 SMN1; SMN2 (0.53) RAB9AALDH1A1HTTMAPTKMT2A
SCHEMBL4569778 0.82 MEN1 (0.53) RAB9AALDH1A1HTTMAPTKMT2A
SCHEMBL27807412 0.82 MAPT (0.51) RAB9AALDH1A1HTTMAPTKMT2A
SCHEMBL173846 0.82 STING1 (0.53) RAB9AHTTMAPTKMT2AMEN1
SCHEMBL175596 0.80 MEN1 (0.56) RAB9AALDH1A1MAPTKMT2AMEN1
SCHEMBL174473 0.80 MEN1 (0.55) RAB9AALDH1A1HTTMAPTKMT2A
SCHEMBL174930 0.79 RAB9A (0.52) RAB9AALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed